Cutera, Inc. (CUTR) Stock Analysis

Cutera, Inc. (CUTR) Healthcare & Pipeline Overview

Cutera, Inc. is a medical device company specializing in laser and energy-based aesthetic systems, offering a diverse portfolio of products like Secret PRO and truSculpt for skin resurfacing and body sculpting. The company targets a global market of practitioners, including dermatologists and plastic surgeons, through a direct sales force.

What Is the Investment Thesis for CUTR?

Cutera, Inc. operates in the growing aesthetic medical device market, driven by increasing demand for non-invasive cosmetic procedures. The company's diverse product portfolio, including innovative systems like Secret PRO and truSculpt, positions it to capture market share. However, with a negative profit margin of -76.7% and a market cap of $1.96M, the company faces challenges in achieving profitability and scaling its operations. Key growth catalysts include expanding its direct sales force and launching new products. Potential risks include competition from established players and the need for regulatory approvals. Investors should closely monitor Cutera's ability to improve its financial performance and capitalize on market opportunities.

Based on FMP financials and quantitative analysis

CUTR Key Highlights

Cutera operates in the medical device industry, specifically focusing on laser and energy-based aesthetic systems.

• The company's product portfolio includes devices for skin resurfacing, body sculpting, hair removal, and tattoo removal.
• Cutera markets and sells its products through a direct sales force to plastic surgeons, dermatologists, and other qualified practitioners.
• Cutera's gross margin is 19.5%.
• Cutera's profit margin is -76.7%.

Who Are CUTR's Competitors?

CUTR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CUTR's Key Strengths?

Diverse product portfolio of laser and energy-based aesthetic systems.

• Direct sales force targeting key practitioners.
• Established brand recognition in the aesthetic market.
• Comprehensive service and support network.

What Are CUTR's Weaknesses?

Negative profit margin.

• High dependence on direct sales force.
• Limited geographic diversification.
• Small market capitalization.

What Could Drive CUTR Stock Higher?

Launch of new aesthetic devices and technologies.

• Expansion of the direct sales force.
• Increasing market penetration in key geographic regions.
• Development and marketing of skincare products.

What Are the Key Risks for CUTR?

Financial-distress signal — its Altman Z-Score of -2.78 sits in the distress zone (elevated bankruptcy risk).

• Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 7 reported quarters.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Competition from established players with greater resources.
• Technological obsolescence of existing products.
• Regulatory changes impacting the aesthetic market.
• Negative profit margin and financial performance.
• Economic downturns affecting consumer spending on aesthetic procedures.

What Are the Growth Opportunities for CUTR?

• Growth opportunity 1: Expanding the direct sales force to increase market penetration and drive revenue growth. A larger sales team can reach more practitioners and promote Cutera's products more effectively. The global aesthetics market is projected to reach $147.9 billion by 2028, providing a significant opportunity for Cutera to expand its sales and market share. This expansion is an ongoing effort, with potential for increased sales in the next 1-2 years.
• Growth opportunity 2: Launching new and innovative products to address unmet needs in the aesthetic market. Cutera's research and development efforts can lead to the introduction of new devices and technologies that attract new customers and drive revenue growth. The market for non-invasive aesthetic procedures is expected to grow at a CAGR of 9.8% from 2021 to 2028, indicating a strong demand for innovative solutions. New product launches are anticipated within the next 2-3 years.
• Growth opportunity 3: Increasing international expansion to tap into new markets and diversify revenue streams. Cutera can expand its presence in regions with high growth potential, such as Asia-Pacific and Latin America. The Asia-Pacific aesthetic market is projected to grow at the highest CAGR during the forecast period, driven by increasing disposable incomes and a growing awareness of aesthetic procedures. International expansion is an ongoing process, with potential for significant growth in the next 3-5 years.
• Growth opportunity 4: Enhancing customer relationships through improved service and support. Providing excellent customer service and support can increase customer loyalty and drive repeat business. The aesthetics market is highly competitive, and customer satisfaction is crucial for retaining customers and attracting new ones through referrals. Ongoing efforts to improve customer service are expected to yield positive results in the next 1-2 years.
• Growth opportunity 5: Developing and marketing skincare products to complement its aesthetic devices. Cutera can leverage its expertise in aesthetics to create and sell skincare products that enhance the results of its devices and provide an additional revenue stream. The development and marketing of skincare products are expected to contribute to revenue growth in the next 2-3 years.

What Are CUTR's Competitive Advantages?

• Proprietary technology in laser and energy-based aesthetic systems.
• Established relationships with plastic surgeons and dermatologists.
• Comprehensive service and support network.
• Brand recognition in the aesthetic market.

What Does CUTR Do?

Cutera, Inc., founded in 1988 and headquartered in Brisbane, California, is a global medical device company focused on researching, developing, manufacturing, marketing, and servicing laser and energy-based aesthetic systems. The company's evolution has been marked by continuous innovation in aesthetic technologies, catering to the growing demand for non-invasive and minimally invasive cosmetic procedures. Cutera's product portfolio includes a range of devices, such as Secret PRO, which combines fractional CO2 laser technology with radio frequency (RF) microneedling for skin resurfacing and dermal remodeling. truSculpt flex is another key product, utilizing bio-electrical muscle stimulation for body sculpting. Other notable products include excel V+ for vascular and pigmented lesion treatment, truSculpt iD for non-surgical body sculpting, and enlighten platform for tattoo removal. The company also offers the excel HR platform for hair removal and the xeo platform, a multi-application system for various aesthetic treatments. Cutera distributes skincare products and provides post-warranty services, enhancing its customer relationships. The company markets its products through a direct sales force, targeting plastic surgeons, dermatologists, and other qualified practitioners globally.

What Products and Services Does CUTR Offer?

• Researches and develops laser and energy-based aesthetic systems.
• Manufactures aesthetic devices for skin resurfacing, body sculpting, and hair removal.
• Markets its products to plastic surgeons, dermatologists, and other qualified practitioners.
• Services and supports its installed base of aesthetic systems.
• Offers post-warranty services through extended service contracts or direct billing.
• Distributes skincare products to complement its aesthetic devices.
• Provides pulsed light hand pieces for various aesthetic treatments.
• Sells hand piece refills, cycle refills, consumable tips, and marketing brochures through its website.

How Does CUTR Make Money?

• Sells laser and energy-based aesthetic systems to practitioners.
• Generates revenue from post-warranty service contracts and direct billing.
• Distributes skincare products to complement its aesthetic devices.
• Sells hand piece refills, cycle refills, and consumable tips.

What Industry Does CUTR Operate In?

Cutera operates within the medical aesthetics industry, which is experiencing growth driven by increasing demand for non-invasive and minimally invasive cosmetic procedures. The market includes established players like Cynosure, Candela, and Alma Lasers, as well as smaller, innovative companies. Cutera differentiates itself through its diverse product portfolio and focus on advanced technologies like fractional CO2 and RF microneedling. The industry is subject to regulatory oversight and requires ongoing innovation to meet evolving consumer preferences. Market trends include a growing emphasis on personalized treatments and the integration of digital technologies.

Who Are CUTR's Key Customers?

• Plastic surgeons
• Dermatologists
• Gynecologists
• Family practitioners
• Primary care physicians

Company Profile

Cutera, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Brisbane, US. The company is led by CEO Taylor C. Harris. CUTR has traded publicly since 2004.

Cutera, Inc. Financial Trajectory

Cutera, Inc. (CUTR) reported $32.5M in revenue for Q3 FY2024, a decline of 5.5% compared to the prior quarter. The company recorded a net loss of $39.0M, with diluted EPS of $-1.94. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely.

How Cutera, Inc. Is Valued

Cutera, Inc. carries a market capitalization of $1.96M, placing it in the micro-cap category.

Return on equity for Cutera, Inc. stands at 174.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -47.0%, showing how much profit it generates from its asset base. A current ratio of 3.07 indicates the company holds enough short-term assets to cover its near-term obligations.

Cutera, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.78 places it in the distress zone, a signal of elevated financial risk.

Cutera, Inc. has missed Wall Street's EPS estimate in 6 of its last 7 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 63.3% below estimates on average.

Wall Street analysts project Cutera, Inc. revenue of about $161.3M for fiscal 2026, with EPS near $-1.94.

The most recent 11 insider filings for Cutera, Inc. break down as 9 sales and 2 purchases. On net that is roughly 3K shares acquired (about $5K) — insiders putting money in tends to read as conviction.

CUTR Financials

CUTR Latest News

CUTR Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources